183 related articles for article (PubMed ID: 37999368)
1. Immunogenicity of
Croia L; Boscato Sopetto G; Zanella I; Caproni E; Gagliardi A; Tamburini S; König E; Benedet M; Di Lascio G; Corbellari R; Grandi A; Tomasi M; Grandi G
Membranes (Basel); 2023 Nov; 13(11):. PubMed ID: 37999368
[TBL] [Abstract][Full Text] [Related]
2. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
[TBL] [Abstract][Full Text] [Related]
3. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
4. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen.
Fantappiè L; de Santis M; Chiarot E; Carboni F; Bensi G; Jousson O; Margarit I; Grandi G
J Extracell Vesicles; 2014; 3():. PubMed ID: 25147647
[TBL] [Abstract][Full Text] [Related]
6. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
[TBL] [Abstract][Full Text] [Related]
7. Delivery of foreign antigens by engineered outer membrane vesicle vaccines.
Chen DJ; Osterrieder N; Metzger SM; Buckles E; Doody AM; DeLisa MP; Putnam D
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3099-104. PubMed ID: 20133740
[TBL] [Abstract][Full Text] [Related]
8. Bacterial-Derived Outer Membrane Vesicles are Potent Adjuvants that Drive Humoral and Cellular Immune Responses.
Prior JT; Davitt C; Kurtz J; Gellings P; McLachlan JB; Morici LA
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498352
[TBL] [Abstract][Full Text] [Related]
9. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
[TBL] [Abstract][Full Text] [Related]
10. Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach.
Daleke-Schermerhorn MH; Felix T; Soprova Z; Ten Hagen-Jongman CM; Vikström D; Majlessi L; Beskers J; Follmann F; de Punder K; van der Wel NN; Baumgarten T; Pham TV; Piersma SR; Jiménez CR; van Ulsen P; de Gier JW; Leclerc C; Jong WS; Luirink J
Appl Environ Microbiol; 2014 Sep; 80(18):5854-65. PubMed ID: 25038093
[TBL] [Abstract][Full Text] [Related]
11. Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro.
Bartolini E; Ianni E; Frigimelica E; Petracca R; Galli G; Berlanda Scorza F; Norais N; Laera D; Giusti F; Pierleoni A; Donati M; Cevenini R; Finco O; Grandi G; Grifantini R
J Extracell Vesicles; 2013; 2():. PubMed ID: 24009891
[TBL] [Abstract][Full Text] [Related]
12. Robust Immune Response Induced by
Barbosa MMF; Kanno AI; Barazzone GC; Rodriguez D; Pancakova V; Trentini M; Faquim-Mauro EL; Freitas AP; Khouri MI; Lobo-Silva J; Goncalves VM; Schenkman RPF; Tanizaki MM; Boraschi D; Malley R; Farias LP; Leite LCC
Int J Nanomedicine; 2021; 16():7153-7168. PubMed ID: 34712047
[TBL] [Abstract][Full Text] [Related]
13. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.
Lei EK; Azmat A; Henry KA; Hussack G
Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192
[TBL] [Abstract][Full Text] [Related]
14. Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.
Rollier CS; Dold C; Marsay L; Linder A; Green CA; Sadarangani M; Norheim G; Derrick JP; Feavers IM; Maiden MCJ; Pollard AJ
mSphere; 2022 Feb; 7(1):e0067421. PubMed ID: 35080470
[TBL] [Abstract][Full Text] [Related]
15. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P
Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064
[TBL] [Abstract][Full Text] [Related]
16. Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation.
van den Berg van Saparoea HB; Houben D; de Jonge MI; Jong WSP; Luirink J
Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29439988
[TBL] [Abstract][Full Text] [Related]
17. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor.
Wang S; Huang W; Li K; Yao Y; Yang X; Bai H; Sun W; Liu C; Ma Y
Int J Nanomedicine; 2017; 12():6813-6825. PubMed ID: 28979120
[TBL] [Abstract][Full Text] [Related]
18. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.
Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP
Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333
[TBL] [Abstract][Full Text] [Related]
19. An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2.
Thapa HB; Müller AM; Camilli A; Schild S
Front Microbiol; 2021; 12():752739. PubMed ID: 34803974
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Protective Activity of Tumor-Specific Epitopes Engineered in Bacterial Outer Membrane Vesicles.
Grandi A; Tomasi M; Zanella I; Ganfini L; Caproni E; Fantappiè L; Irene C; Frattini L; Isaac SJ; König E; Zerbini F; Tavarini S; Sammicheli C; Giusti F; Ferlenghi I; Parri M; Grandi G
Front Oncol; 2017; 7():253. PubMed ID: 29164053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
